Medicare GLP-1 Bridge Program: $50 GLP-1s Explained

Quick answer: The Medicare GLP-1 Bridge is a temporary Medicare program, running July 1, 2026 through December 31, 2027, that lets eligible people with Medicare Part D get certain GLP-1 weight-loss drugs for $50 a month. Eligibility depends on your Part D coverage, your diagnosis, and your BMI — and the program’s rules are set by Medicare, not by your pharmacy or doctor’s office.

If you’ve searched GLP-1 prices while on Medicare, you’ve probably hit a wall: traditional Medicare historically didn’t cover weight-loss drugs, and brand-name GLP-1s can run $1,000 or more a month without coverage. The Bridge program is Medicare’s attempt to close that gap for a defined group of people, for a defined window of time. Here’s what it does, who it covers, and — importantly — who it doesn’t.

What is the Medicare GLP-1 Bridge program?

It’s a short-term demonstration program run by CMS, the agency that runs Medicare (source: Medicare.gov). Starting July 1, 2026, Medicare provides eligible Part D beneficiaries with access to certain GLP-1 drugs at a flat $50 monthly copay — outside the normal Part D benefit structure. That means the $50 doesn’t count toward your plan’s deductible or your yearly out-of-pocket limit, and it isn’t reduced further for people with low-income subsidies.

The drugs covered under the Bridge, per Medicare’s own fact sheet, are:

• Foundayo (tablet)
• Wegovy (injection or tablet)
• Zepbound (KwikPen only — the single-dose pen and vials are not covered)

Note what’s missing: Ozempic is not part of the Bridge, and neither are the other diabetes-labeled GLP-1s. This program is for the weight-loss-labeled GLP-1s. If you take Ozempic for type 2 diabetes, your coverage runs through your normal Part D plan, not through the Bridge.

Who qualifies for the Medicare GLP-1 Bridge?

Medicare sets four requirements, and you must meet all of them. Summarized in plain language:

1. You have Medicare Part D drug coverage — through either a standalone drug plan or a Medicare health plan that includes drug coverage. Certain plan types (like PACE organizations and some private fee-for-service plans) don’t qualify.
2. You’re not already receiving a GLP-1 through your Medicare drug plan. If your plan already covers your GLP-1 — for example, because you have type 2 diabetes — you keep using that route. The Bridge isn’t for you.
3. You don’t have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. These conditions can make a GLP-1 coverable through your regular plan anyway, so the Bridge points you back to your plan for them.
4. You’re at least 18, and at least one of these is true: a BMI of 35 or higher; a BMI of 30 or higher plus certain heart failure, hard-to-control high blood pressure, or stage 3a-or-above chronic kidney disease; or a BMI of 27 or higher plus prediabetes, a prior heart attack, stroke, or blocked arteries in your legs or arms.

Notice the pattern: the Bridge targets people whose GLP-1 would be prescribed for weight and heart risk, not for diabetes. If your diagnosis is type 2 diabetes, your first move isn’t the Bridge — it’s your plan’s coverage of diabetes-labeled GLP-1s, which our guide to GLP-1 drugs sorts out brand by brand.

How much does the Bridge cost out of pocket?

Eligible beneficiaries pay $50 per month for a one-month supply, regardless of income, for the drugs on the covered list. That’s the headline. Three details trip people up, so they’re worth stating plainly:

• The $50 doesn’t count toward your plan deductible or your annual out-of-pocket maximum. It’s a parallel cost, not a step toward the normal Part D milestones.
• There’s no low-income subsidy on top of it — even people who normally pay reduced copays pay the $50 under this program.
• These drugs aren’t eligible for the Medicare Prescription Payment Plan (the program that lets you spread drug costs over the year).

Refills don’t need fresh Medicare approval as long as you stay on the same drug, even if your dose changes. Coverage for other costs of diabetes care, like monitoring supplies, follows different rules entirely — our guide to insurance coverage for diabetes supplies covers that side.

How do you actually sign up or check eligibility?

The process runs through your doctor and pharmacist, not through a website form you fill out alone. The sequence Medicare describes:

1. Talk to your doctor about whether a GLP-1 is right for you and whether you meet the Bridge criteria.
2. If one of the covered drugs fits, your doctor sends the prescription to your pharmacy.
3. Your pharmacy may contact you for your Medicare ID number (it’s printed on your card; if you don’t have it handy, the pharmacy can look it up with the last four digits of your Social Security number).
4. Your doctor submits a prior-authorization form to Medicare.
5. You get a letter from Medicare confirming coverage, then pick up your medicine and pay $50.

Before any of that, the fastest checks are free: visit Medicare.gov (the GLP-1 Bridge pages there include an eligibility checker) or call 1-800-MEDICARE (1-800-633-4227) — TTY users can call 1-877-486-2048. Your plan’s member services line can also tell you whether your plan type participates.

What are the honest caveats?

This program has a built-in expiration: it runs through December 31, 2027. What happens after — whether it’s extended, replaced by something permanent, or ends — isn’t something anyone can promise today. A few more things to keep in mind:

• Program details can change. The covered drug list, the $50 copay, and the eligibility criteria are set by Medicare and could be revised. Verify current rules at Medicare.gov before making plans.
• Not all GLP-1s are covered. The Bridge covers three weight-loss-labeled products; Ozempic, Mounjaro, and other diabetes-labeled GLP-1s go through your regular plan.
• The $50 is per month, not a treatment guarantee. Staying on the drug still means staying eligible, refilling on time, and your doctor confirming it’s still appropriate.
• Weight-loss drugs still require the basics. No GLP-1 replaces eating habits and movement — the medication changes how hungry you feel, not what your meals are made of.

If the Bridge doesn’t fit your situation, the conversation shifts back to your Part D plan: which GLP-1s it covers, for which diagnoses, and at what tier. That’s a different negotiation, but a very winnable one for people with diabetes diagnoses — which is why knowing which drug family you’re actually asking about matters before you call.

What if you don’t qualify for the Bridge?

Not qualifying isn’t a dead end — it usually means your situation runs through a different door:

• Type 2 diabetes diagnosis? Medicare plans can cover diabetes-labeled GLP-1s like Ozempic or Mounjaro when the diagnosis supports them. Ask your plan specifically which GLP-1s are on formulary and what the prior-authorization requirements are.
• Heart failure or chronic kidney disease? Some SGLT2 inhibitors are strongly covered for those conditions, and your doctor may consider that family instead.
• Coverage denied or unaffordable? Manufacturer savings programs, pharmacy discount programs, and state pharmaceutical assistance programs each have their own rules — none are guaranteed, but they’re worth a phone call before assuming the sticker price is the only price.
• Approaching the donut-hole math? Because the Bridge’s $50 doesn’t count toward your normal out-of-pocket totals, some people do better staying on plan-covered drugs even at a higher copay. If you’re close to your yearly out-of-pocket limit, ask your plan to run the comparison.

The honest bottom line: the Bridge is one narrow, temporary answer to one narrow problem. Your actual cheapest path depends on your diagnosis, your plan, and the year — which is exactly why the free checks at Medicare.gov and 1-800-MEDICARE come before anything else in this article.

Frequently asked questions

What is the Medicare GLP-1 Bridge program? It’s a temporary Medicare program, July 1, 2026 through December 31, 2027, that provides eligible Part D beneficiaries with certain GLP-1 weight-loss drugs — Foundayo, Wegovy, and Zepbound (KwikPen) — for a $50 monthly copay.

Who qualifies for the Medicare GLP-1 Bridge? You need Medicare Part D coverage, must not already get a GLP-1 through your plan, must not have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, and must be 18 or older with a BMI-based qualifying condition such as BMI 35+, BMI 30+ with heart failure or uncontrolled high blood pressure, or BMI 27+ with prediabetes or prior cardiovascular events.

How much do GLP-1s cost under the Bridge program? Eligible beneficiaries pay $50 per month for a one-month supply, regardless of income. The $50 doesn’t count toward the Part D deductible or yearly out-of-pocket limit, and there’s no additional low-income subsidy.

Is Ozempic covered by the Medicare GLP-1 Bridge? No. Ozempic and other diabetes-labeled GLP-1s are not part of the Bridge. If you take a GLP-1 for type 2 diabetes, coverage runs through your regular Part D plan instead.

How do I apply for the Medicare GLP-1 Bridge? Start with your doctor, who sends the prescription to your pharmacy; the doctor then submits a prior-authorization form to Medicare, and you receive a confirmation letter before paying $50 at the pharmacy. To check eligibility first, visit Medicare.gov or call 1-800-MEDICARE (1-800-633-4227).

This guide is also available in Spanish: Programa puente GLP-1 de Medicare: GLP-1 a 50 $ explicado.

Full Guide

Educational content only — not a substitute for advice from your doctor or pharmacist. Always work with your care team.